Abstract
Ocular infection and inflammation are common and are associated with myriad ocular conditions ranging from mild disease to blinding conditions. There are numerous anti-invectives with spectra against inciting pathogens. Given the potential for ocular infections to rapidly progress initial broad spectrum therapy is usually required, with therapy tailored as microbiological identification and sensitivities become available. The emergence of antibiotic resistance has become a major health problem. Anti-inflammatory therapy can be institutes to prevent ocular symptoms and end-organ damage. A therapy should be selected which is potent enough to interrupt the inflammatory cascades in play, but which avoids potential side effects. Glucocorticoids, NSAIDs, and biological agents may be used singularly or in combination. New drug delivery devices may allow for better local treatment of chronic ocular inflammation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Garg P, Roy A, Roy S (2016) Update on fungal keratitis. Curr Opin Ophthalmol 27(4):333–339. doi:10.1097/ICU.0000000000000272
Grzybowski A, Kuklo P, Pieczynski J, Beiko G (2016) A review of preoperative manoeuvres for prophylaxis of endophthalmitis in intraocular surgery: topical application of antibiotics, disinfectants, or both? Curr Opin Ophthalmol 27(1):9–23. doi:10.1097/ICU.0000000000000216
Kim SJ, Schoenberger SD, Thorne JE, Ehlers JP, Yeh S, Bakri SJ (2015) Topical nonsteroidal anti-inflammatory drugs and cataract surgery: a report by the American Academy of Ophthalmology. Ophthalmology 122(11):2159–2168. doi:10.1016/j.ophtha.2015.05.014
Kim CH, Chen MF, Coleman AL (2017) Adjunctive steroid therapy versus antibiotics alone for acute endophthalmitis after intraocular procedure. Cochrane Database Syst Rev 2:CD012131. doi:10.1002/14651858.CD012131.pub2
Lakhundi S, Siddiqui R, Khan NA (2017) Pathogenesis of microbial keratitis. Microb Pathog 104:97–109. doi:10.1016/j.micpath.2016.12.013
Palioura S, Henry CR, Amescua G, Alfonso EC (2016) Role of steroids in the treatment of bacterial keratitis. Clin Ophthalmol 10:179–186. doi:10.2147/OPTH.S80411
Tsatsos M, MacGregor C, Athanasiadis I, Moschos MM, Hossain P, Anderson D (2016) Herpes simplex virus keratitis: an update of the pathogenesis and current treatment with oral and topical antiviral agents. Clin Exp Ophthalmol 44(9):824–837. doi:10.1111/ceo.12785
Wilson DJ, Schutte SM, Abel SR (2015) Comparing the efficacy of ophthalmic NSAIDs in common indications: a literature review to support cost-effective prescribing. Ann Pharmacother 49(6):727–734. doi:10.1177/1060028015574593
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Rosenblatt, M.I. (2017). Anti-Infective and Anti-Inflammatory Pharmacotherapies. In: Whitcup, S., Azar, D. (eds) Pharmacologic Therapy of Ocular Disease. Handbook of Experimental Pharmacology, vol 242. Springer, Cham. https://doi.org/10.1007/164_2017_26
Download citation
DOI: https://doi.org/10.1007/164_2017_26
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-58288-7
Online ISBN: 978-3-319-58290-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)